Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: post hoc analysis of patients receiving cannabidiol in two randomized controlled trials.
Stėphane AuvinCharlotte NortvedtDouglas S FullerFarhad SahebkarPublished in: Epilepsia (2023)
Drop and total seizure-free days represent potential new and clinically meaningful endpoints for future RCTs in patients with LGS.